# Ypsomed starts production at new €81M medtech plant in Schwerin

Ypsomed AG has started production at its newly built plant in Schwerin, Germany, with an investment of about €81 million. The facility will produce insulin syringes and pump systems, and is expected to create 150 jobs.

- Type: New facility
- Announced: 2019-08-22
- Where: Schwerin, Mecklenburg-Vorpommern, Germany
- Value: $90.0M (81.0M EUR)
- Jobs: 150
- Starts operating: 22 Aug 2019
- Status: completed
- Capacity: 10 million infusion sets per year
- Products: insulin syringes, insulin pump systems
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Ypsomed](https://endata.com/companies/9625.md)

## Sources

- [welt.de](https://www.welt.de/regionales/mecklenburg-vorpommern/article198954739/Millionen-Investition-Richtfest-fuer-Medizintechnik-Werk.html), 2019-08-21: "Das Schweizer Medizintechnik-Unternehmen Ypsomed startet am Donnerstag in seinem neu errichteten Werk in Schwerin die Produktion."
- [ypsomed.com](https://www.ypsomed.com/en/news-insights/news/press-releases/news-reader-detail-page/ypsomed-opens-production-plant-in-schwerin-germany), 2019-08-22: "In Schwerin, we have built a state-of-the-art production plant for medical technology."
- [b2b-wirtschaft.de](https://www.b2b-wirtschaft.de/schwerin/artikel/schweizer-medizintechnikhersteller-ypsomed-eroeffnet-neues-werk), 2019-12-09: "Nach knapp zweijähriger Bauzeit wurde am 22. August 2019 ... das neue Produktionswerk des Schweizer Medizintechnikunternehmens Ypsomed AG im Industriepark Schwerin eröffnet."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.